ATRI - Atrion Corporation
| Previous Close | 789.51 |
| Open | 791.89 |
| Bid | 787.00 x 800 |
| Ask | 798.92 x 800 |
| Day's Range | 791.89 - 795.00 |
| 52 Week Range | 516.85 - 803.00 |
| Volume | 3,604 |
| Avg. Volume | 10,132 |
| Market Cap | 1.473B |
| Beta (3Y Monthly) | 0.28 |
| PE Ratio (TTM) | 42.02 |
| EPS (TTM) | 18.92 |
| Earnings Date | Feb 25, 2019 - Mar 1, 2019 |
| Forward Dividend & Yield | 5.40 (0.68%) |
| Ex-Dividend Date | 2018-11-30 |
| 1y Target Est | 300.00 |
- Simply Wall St.•10 days ago
Have Insiders Been Selling Atrion Corporation (NASDAQ:ATRI) Shares?
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! We often see insiders buying up shares Read More...
- Simply Wall St.•last month
Should You Like Atrion Corporation’s (NASDAQ:ATRI) High Return On Capital Employed?
Today we'll evaluate Atrion Corporation (NASDAQ:ATRI) to determine whether it could have potential as an investment idea. To be precise, we'll consider its Return On Capital Employed (ROCE), as that Read More...
- Simply Wall St.•2 months ago
Does Atrion Corporation’s (NASDAQ:ATRI) CEO Pay Compare Well With Peers?
In 2011 David Battat was appointed CEO of Atrion Corporation (NASDAQ:ATRI). This report will, first, examine the CEO compensation levels in comparison to CEO compensation at companies of similar size. Read More...
- Associated Press•3 months ago
Atrion: 3Q Earnings Snapshot
The Allen, Texas-based company said it had profit of $4.96 per share. The medical device maker posted revenue of $39.3 million in the period. Atrion shares have increased 13 percent since the beginning ...
- Simply Wall St.•3 months ago
Do Insiders Own Lots Of Shares In Atrion Corporation (NASDAQ:ATRI)?
Every investor in Atrion Corporation (NASDAQ:ATRI) should be aware of the most powerful shareholder groups. Large companies usually have institutions as shareholders, and we usually see insiders owning shares in Read More...
- Simply Wall St.•4 months ago
Does Atrion Corporation’s (NASDAQ:ATRI) PE Ratio Warrant A Buy?
This article is intended for those of you who are at the beginning of your investing journey and want to begin learning about how to value company based on its Read More...
- Simply Wall St.•5 months ago
Can Atrion Corporation’s (NASDAQ:ATRI) ROE Continue To Surpass The Industry Average?
This analysis is intended to introduce important early concepts to people who are starting to invest and want to learn about Return on Equity using a real-life example. Atrion CorporationRead More...
- Associated Press•6 months ago
Atrion: 2Q Earnings Snapshot
On a per-share basis, the Allen, Texas-based company said it had net income of $4.74. Earnings, adjusted for pretax gains, were $4.70 per share. The medical device maker posted revenue of $38.8 million ...
- ACCESSWIRE•9 months ago
Blog Exposure - FDA Approved Expanded Indications for TransEnterix's Senhance Surgical System
LONDON, UK / ACCESSWIRE / May 31, 2018 / If you want access to our free research report on TransEnterix, Inc. (NYSE: TRXC), all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=TRXC as the Company's latest news hit the wire. On May 29, 2018, the Company announced that the US Food and Drug Administration (FDA) has granted 510(k) clearance for expanded indications of the Company's Senhance Surgical System for laparoscopic inguinal hernia and laparoscopic cholecystectomy (gallbladder removal) surgery.
- Simply Wall St.•9 months ago
Where Atrion Corporation (NASDAQ:ATRI) Stands In Terms Of Earnings Growth Against Its Industry
Assessing Atrion Corporation’s (NASDAQ:ATRI) past track record of performance is a useful exercise for investors. It allows us to understand whether the company has met or exceed expectations, which isRead More...
- ACCESSWIRE•11 months ago
Free Post Earnings Research Report: Mettler-Toledo’s Quarterly Earnings Increased 13.07%
Stock Monitor: Atrion Post Earnings Reporting LONDON, UK / ACCESSWIRE / March 12, 2018 / Active-Investors.com has just released a free earnings report on Mettler-Toledo International Inc. (NYSE: MTD ) ...
- Simply Wall St.•11 months ago
Atrion Corporation (NASDAQ:ATRI) Delivered A Better ROE Than The Industry, Here’s Why
Atrion Corporation (NASDAQ:ATRI) delivered an ROE of 19.85% over the past 12 months, which is an impressive feat relative to its industry average of 11.26% during the same period. WhileRead More...
